GNTA Balance Sheet, Income & Cash Flow

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Line item	Q2 19	Q4 19	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q2 24	Q4 24	Q3 25	Q1 26
Cost of Revenue	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	–	0.00	0.00	0.00	0.00	0.00
Gross Profit	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	–	0.00	0.00	0.00	0.00	0.00
Research & Development	0.10	0.10	0.14	–	0.18	–	0.22	–	–	0.01	–	0.09	–	0.20	0.21	0.07	0.14	0.11	0.16	0.07	0.06
Selling, General & Administrative	0.03	0.03	0.03	–	0.03	–	0.06	–	–	0.09	–	0.14	–	0.18	0.08	0.07	0.13	0.14	0.14	0.10	–
Total Operating Expenses	0.13	0.13	0.17	–	0.21	–	0.27	–	–	0.11	–	0.23	–	0.38	0.37	0.14	0.27	0.25	0.30	0.17	0.15
Operating Income	-0.13	-0.13	-0.17	–	-0.21	–	-0.27	–	–	-0.11	–	-0.23	–	-0.38	-0.37	-0.14	-0.27	-0.25	-0.30	-0.17	-0.15
Interest Expense	0.00	0.00	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.01	0.02	0.00
Pre-Tax Income	-0.13	-0.13	-0.17	–	-0.21	–	-0.27	–	–	-0.10	–	-0.12	–	-0.35	-0.37	-0.13	-0.26	-0.22	-0.28	-0.19	-0.13
Income Tax Expense	0.00	0.00	–	–	–	–	–	–	–	–	–	–	–	–	0.00	–	0.00	–	–	–	–
Net Income	-0.13	-0.13	-0.17	–	-0.21	–	-0.27	–	–	-0.10	–	-0.12	–	-0.35	-0.37	-0.13	-0.26	-0.22	-0.28	-0.19	-0.13
EBITDA	–	–	-0.17	–	-0.21	–	-0.27	–	–	-0.10	–	-0.12	–	-0.35	-0.37	-0.13	-0.26	-0.22	-0.28	-0.17	-0.13

Genenta Science SpA